Author/Authors :
AHMADI, Kolsoum Lorestan University of Medical Sciences, Khorramabad , SOLEIMANI, Azam Department of Biology - Science and Research Branch - Islamic Azad University, Tehran , SOLEIMANI MOTLAGH, Shadi Lorestan University of Medical Sciences, Khorramabad , BAHARVAND AHMADI, Shahram Department of Internal Medicine - Artesh University of Medical Sciences, Tehran , ALMASIAN, Mohammad School of Medicine - Lorestan University of Medical Sciences, Khorramabad , KIANI, Ali Asghar Department of Hematology and Blood Transfusion - School of Allied Medical Sciences - Lorestan University of Medical Sciences, Khorramabad
Abstract :
Background: The present research is a case-control study to analyze the influence of pre-miRNA-146a
rs2910164 and pre-miRNA-499 rs3746444 polymorphisms as candidate susceptibility factors for both rheumatoid
arthritis (RA) and systemic lupus erythematosus (SLE).
Methods: Polymorphism in miR146 and miR499 using ARMS-PCR was genotyped on 139 autoimmune disease
(AD) patients (89 RA and 50 SLE) referred to Educational Hospitals of Khorramabad, Lorestan Province, west
of Iran in 2018–2019 and 237 healthy control subjects.
Results: A significant increase in the likelihood of carrying the GC vs. GG of pre-miR146-rs2910164 and T vs
C allele of pre-miR499- rs3746444 in patients with RA was found. On the contrary, patients with RA were less
likely to carry the TC + CC vs TT genotype and the C vs T allele of pre-miR499- rs374644. In females with the
GC vs GG and GC+ CC vs GG genotypes, a significant association was found with the increased risk of RA.
Interestingly, the genotypic combination of TC of the pre-miR499-rs374644 with GG of pre-miR146-rs2910164
more strongly decreased the risk of RA. In patients with SLE, no notable associations were found between both
pre-miRNA-146a rs2910164 and pre-miRNA-499 rs3746444 with risk of disease.
Conclusion: Genetic polymorphisms of miR146 rs2910164 is associated with RA susceptibility especially in
females. Interestingly, there is a potential in miR499 to reduce the risk with the protective effect of gene-gene
interactions on miR146 in RA disease.